About Us

LIke ThisLIke ThisLIke This

About Us

No one can solve the tough challenges of pediatric health care alone. We need to build creative, durable relationships that will spawn new discoveries, improve care and accelerate the benefits for children. Boston Children’s embraces partnerships to fuel greater and faster innovation, ensuring that life-changing visions become reality and create a healthier future for our children. We approach every challenge with the question of how and with whom can we partner to make the work bigger, better, more productive. Join us.
– Sandra L. Fenwick, President and CEO

Since its founding, Boston Children’s Hospital has embodied a culture of innovation, driving research and clinical advances to new levels.

Our commitment to partnerships—across disciplines, with nursing, with Harvard Medical School and other academic medical centers—makes us truly unique.

We’ve created programs to take partnerships to the next level, focusing on collaborations that leverage and optimize the unique assets of each partner to yield an arrangement that is greater than the sum of its parts. Our Technology and Innovation Development Office (TIDO) and Innovation & Digital Health Accelerator (IDHA)—provide a robust foundation for vibrant partnerships with industry and across the innovation community.

Our commitment to partnerships has garnered impressive results:

  • Boston Children’s is the first pediatric organization to partner with Blue Cross Blue Shield of Massachusetts' Alternative Quality Contract (AQC). The AQC offers providers a baseline budget to cover the continuum of care, and has delivered a small yet significant positive effect on preventive and acute-care quality when tied to pay-for-performance models.

  • A partnership between Boston Children’s and Shire, focused on rare diseases, builds on the organizations’ complementary strengths: Boston Children’s research capabilities and Shire’s development and commercialization infrastructure. The goal of the three-year partnership is to develop novel therapies to treat a number of rare pediatric diseases with high unmet medical need.

  • A partnership between Boston Children’s and IBM delivers OPENPediatrics, an interactive digital learning platform, free to clinicians across the globe, exponentially increasing access to essential educational materials and improving the practice of critical care medicine.

  • Boston Children's spun out its molecular medicine laboratory into Claritas Genomics, an independent, first of its kind, pediatric clinical genomics diagnostics company. Cincinnati Children’s Hospital has joined Claritas, beginning the formation of a genomic network of pediatric hospitals.

These programs extend Boston Children's basic science infrastructure. We are home to the world's largest research enterprise based at a pediatric hospital. More than 1,300 scientists comprise our research community, including seven members of the National Academy of Sciences, 12 members of the Institute of Medicine, 14 members of the Howard Hughes Medical Institute and 28 members of the American Society for Clinical Investigation. Our research facilities include more than 800,000 square feet of basic and translational research space and 50,000 square feet of clinical research space. Our current initiatives have attracted a record $308 million in annual funding, including more federal funding than any other pediatric center.

Now, more than ever, we need collaborative leadership to continue to accelerate global pediatric innovations.

LIke ThisLIke ThisLIke This